Top Markets
#1 Siacoin Siacoin +38.17%
#2 Official Trump Official Trump +31.38%
#3 Unit Pump Unit Pump +19.19%
#4 Pump.fun Pump.fun +19.19%
#5 EXOD EXOD +18.93%
#6 MowCat MowCat +18.76%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +18.50%
#8 Melania Meme Melania Meme +18.46%
#9 Mubarak Mubarak +17.60%
#10 The Bitcoin Bull The Bitcoin Bull +14.75%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
NeurAxis, Inc. NeurAxis, Inc.

NeurAxis, Inc.

NRXS
Rank in Stocks #23206
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation... NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
Share Price
$6.17
Last synced: 2026-08-21
Market Cap
$76.98M
Change (1 day)
-0.80%
Change (1 year)
149.80%
Country
US
Trade NeurAxis, Inc. (NRXS)

Category

Healthcare
Revenue for NeurAxis, Inc. (NRXS)
Revenue in Aug 2026 TTM: 0
According to NeurAxis, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NeurAxis, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH